Silo Pharma Provides Details of Patent License Agreement for Psilocybin and Cancer Applications Post published:January 11, 2021 Post category:Press Release
Entheon Biomedical Engages World Renowned Media Personality DJ Skee, AKA Scott Keeney, as Media Advisor Post published:January 11, 2021 Post category:Press Release
Eleusis Accelerates Psychedelic Drug Discovery and Development Team with Appointment of David Nichols, Ph.D., as Director of Molecular Pharmacology Post published:January 11, 2021 Post category:Press Release
Cybin Partners with Kernel to Leverage its Breakthrough Neuroimaging Technology for Psychedelic Therapeutics Post published:January 11, 2021 Post category:Press Release
Champignon Brands Announces New CFO and New General Counsel Post published:January 11, 2021 Post category:Press Release
Mydecine Innovations Group Appoints Gordon Neal to Board of Directors and Dean Ditto as Chief Financial Officer Post published:January 11, 2021 Post category:Press Release
NeonMind Announces Grants Pursuant to Stock Option Plan Post published:January 11, 2021 Post category:Press Release
Lobe Sciences Announces Changes to Board of Directors Post published:January 8, 2021 Post category:Press Release
Psychedelic Bulletin: MindMed Raises $92.1m; Mount Sinai Establishes Psychedelics Centre; More Legal Exemptions for Psilocybin in Canada Post published:January 8, 2021 Post category:Psychedelic Bulletin
Review of Bipolar Disorders Confirms Early Diagnosis and Treatment Can Improve Patient Quality of Life Post published:January 8, 2021 Post category:Press Release